EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens

Lucile Plumet iD, Denis Costechareyre, Jean-Philippe Lavigne iD, Karima Kissa, Virginie Molle iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00829-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Lucile Plumet und 4 weiteren Autor:innen. Beteiligte Einrichtung: VBIC, INSERM U1047, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Zebrafish, Phage Therapy, Bacterial Infections, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating prevalence of antibiotic-resistant bacterial infections necessitates urgent alternative therapeutic strategies. Phage therapy, which employs bacteriophages to specifically target pathogenic bacteria, emerges as a promising solution. This review examines the efficacy of phage therapy in zebrafish models, both embryos and adults, which are proven and reliable for simulating human infectious diseases. We synthesize findings from recent studies that utilized these models to assess phage treatments against various bacterial pathogens, including Enterococcus faecalis , Pseudomonas aeruginosa , Mycobacterium abscessus , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , and Escherichia coli . Methods of phage administration, such as circulation injection and bath immersion, are detailed alongside evaluations of survival rates and bacterial load reductions. Notably, combination therapies of phages with antibiotics show enhanced efficacy, as evidenced by improved survival rates and synergistic effects in reducing bacterial loads. We also discuss the transition from zebrafish embryos to adult models, emphasizing the increased complexity of immune responses. This review highlights the valuable contribution of the zebrafish model to advancing phage therapy research, particularly in the face of rising antibiotic resistance and the urgent need for alternative treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishPhage TherapyBacterial InfectionsDisease Models, AnimalAnti-Bacterial AgentsAnimalsHumansBacteriophages

Stichwörter der Autor:innen

animal modelantibioticsbacteriaphage therapyzebrafish

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • VBIC, INSERM U1047, University of Montpellier, Montpellier, France.
  • Greenphage, Cap Alpha, Clapiers, France.
  • VBIC, INSERM U1047, University of Montpellier, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, France.

ORCID-Profile: Lucile Plumet, Jean-Philippe Lavigne, Virginie Molle

Zitieren

APA

Plumet, L., Costechareyre, D., Lavigne, J. P., Kissa, K., & Molle, V. (2024). Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00829-24

Vancouver

Plumet L, Costechareyre D, Lavigne JP, Kissa K, Molle V. Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00829-24

BibTeX
@article{Plumet2024,
  author = {Plumet, Lucile and Costechareyre, Denis and Lavigne, Jean-Philippe and Kissa, Karima and Molle, Virginie},
  title = {Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00829-24}
}
Kostenlos starten →